Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H. Serrano‐Wu, Brian K. Hubbard, Renee Commerford et al.|ACS Medicinal Chemistry Letters|2012Cited by 27
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Michael H. Serrano‐Wu, Ricardo E. Chatelain et al.|Journal of Medicinal Chemistry|2017Cited by 18
A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition riskYoung‐Shin Kwak, Michael H. Serrano‐Wu, Gary M. Coppola et al.|Bioorganic & Medicinal Chemistry Letters|2011Cited by 3